Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18457 patients

Metabolism: Clinical and Experimental

Volumn 64, Issue 10, 2015, Pages 1224-1234

  Tie, Hong Tao ^a   Shi, Rui ^a   Li, Zhen Han ^b   Zhang, Min ^a   Zhang, Cheng ^a   Wu, Qing Chen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Major adverse cardiovascular events; Meta analysis; Metabolic syndrome; Revascularization

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; EMBASE; GENETIC HETEROGENEITY; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MEDICATION COMPLIANCE; MEDLINE; META ANALYSIS; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THERAPY EFFECT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; COMPLICATION; MORTALITY; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; METABOLIC SYNDROME X; MYOCARDIAL REVASCULARIZATION; RISK FACTORS;

EID: 84941599157     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.06.019     Document Type: Review

References (46)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 3 2014 e28 e292
2. S. Deb, H.C. Wijeysundera, D.T. Ko, H. Tsubota, S. Hill, and S.E. Fremes Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review JAMA 310 19 2013 2086 2095
3. K.G. Alberti, P. Zimmet, and J. Shaw The metabolic syndrome - a new worldwide definition Lancet 366 9491 2005 1059 1062
4. R. Kahn, J. Buse, E. Ferrannini, and M. Stern The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 9 2005 2289 2304
5. B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, and et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 4 2001 683 689
6. J.B. Meigs, M.K. Rutter, L.M. Sullivan, C.S. Fox, R.B. D'Agostino, and P.W. Wilson Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome Diabetes Care 30 5 2007 1219 1225
7. H.T. Cheng, J.W. Huang, C.K. Chiang, C.J. Yen, K.Y. Hung, and K.D. Wu Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly J Clin Endocrinol Metab 97 4 2012 1268 1276
8. S. Novo, A. Peritore, F.P. Guarneri, E. Corrado, F. Macaione, S. Evola, and et al. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study Atherosclerosis 223 2 2012 468 472
9. E. Angeloni, G. Melina, U. Benedetto, S. Refice, F. Capuano, A. Roscitano, and et al. Metabolic syndrome affects midterm outcome after coronary artery bypass grafting Ann Thorac Surg 93 2 2012 537 544
10. H. Bin, Z. Yujie, L. Yuyang, S. Dongmei, Z. Yingxin, J. Dean, and et al. Impact of metabolic syndrome on clinical outcomes after drug-eluting stent implantation in patients with coronary artery disease Angiology 62 6 2011 440 446
11. T. Dohi, K. Miyauchi, T. Kasai, K. Kajimoto, N. Kubota, H. Tamura, and et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome Circ J 73 8 2009 1454 1458
12. K. Kajimoto, T. Kasai, K. Miyauchi, H. Hirose, N. Yanagisawa, T. Yamamoto, and et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery Circ J 72 9 2008 1481 1486
13. V. Kalahasti, D.P. Chew, V. Nambi, S.G. Minor, R. Zuzek, S. Ellis, and et al. Influence of metabolic syndrome on outcome after percutaneous coronary intervention Interv Cardiol 3 6 2011 721 726
14. T. Kasai, K. Miyauchi, K. Kajimoto, N. Kubota, T. Dohi, T. Kurata, and et al. The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization J Hypertens 27 5 2009 1017 1024
15. T. Kasai, K. Miyauchi, K. Kajimoto, N. Kubota, N. Yanagisawa, A. Amano, and et al. Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period Atherosclerosis 207 1 2009 195 199
16. T. Kasai, K. Miyauchi, T. Kurata, S. Okazaki, K. Kajimoto, N. Kubota, and et al. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention Hypertens Res 31 2 2008 235 241
17. A. Kunimura, T. Amano, T. Uetani, K. Harada, T. Yoshida, A. Suzuki, and et al. Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: involvement of coronary plaque composition J Cardiol 61 3 2013 189 195
18. D.J. Maron, W.E. Boden, J.A. Spertus, P.M. Hartigan, G.B. Mancini, S.P. Sedlis, and et al. Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial J Am Coll Cardiol 58 2 2011 131 137
19. T. Mori, Y. Ohashi, J. Ejiri, K. Takatsuki, S. Ichikawa, and K. Awano Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention J Cardiol 46 3 2005 89 96
20. Y. Uchida, S. Ichimiya, H. Ishii, M. Kanashiro, J. Watanabe, D. Yoshikawa, and et al. Impact of metabolic syndrome on various aspects of microcirculation and major adverse cardiac events in patients with ST-segment elevation myocardial infarction Circ J 76 8 2012 1972 1979
21. M. Almalla, J. Schroder, V. Deserno, F. Vogt, R. Koos, K.C. Koch, and et al. Long-term clinical outcome of sirolimus-eluting stent implantation in metabolic syndrome and diabetes J Invasive Cardiol 22 7 2010 317 321
22. G.R. Iturry-Yamamoto, A.C. Zago, E.H. Moriguchi, W.C. Manfroi, J.L. Camargo, J.L. Gross, and et al. Impact of metabolic syndrome and C-reactive protein on outcome after coronary stenting J Endocrinol Invest 32 4 2009 383 386
23. M.S. Ji, M.H. Jeong, Y. Ahn, Y.J. Kim, S.C. Chae, T.J. Hong, and et al. One-year clinical outcomes among patients with metabolic syndrome and acute myocardial infarction Korean Circ J 43 8 2013 519 526
24. J.S. Kim, H.C. Lee, B.K. Choi, H.W. Lee, J.S. Park, Y.H. Lee, and et al. Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation Diabetes Res Clin Pract 88 3 2010 e38 e41
25. J. Li, S.J. Song, J.P. Xu, X.Z. Zhao, Z.W. Xu, X.J. Sun, and et al. Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention Herz 1 2014 129 135
26. J.S. Rana, P.S. Monraats, A.H. Zwinderman, M.P. de Maat, J.J. Kastelein, P.A. Doevendans, and et al. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention Diabetes Care 28 4 2005 873 877
27. E. Stellbrink, J. Schroder, A. Grawe, R. Goebbels, R. Blindt, M. Kelm, and et al. Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation Coron Artery Dis 18 8 2007 601 606
28. K.B. Won, B.K. Kim, H.J. Chang, D.H. Shin, J.S. Kim, Y.G. Ko, and et al. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents Catheter Cardiovasc Interv 83 5 2014 713 720
29. C. Patsa, K. Toutouzas, E. Tsiamis, C. Tsioufis, A. Spanos, A. Karanasos, and et al. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparent Nutr Metab Cardiovasc Dis 23 4 2013 307 313
30. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, and et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 15 2000 2008 2012
31. J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, and M.R. Sydes Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 2007 16
32. G. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, and et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 3rd Symposium on Systematic Reviews: Beyond the Basics 2000
33. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560
34. M. Egger, G.D. Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 1997 629 634
35. R. Hoffmann, E. Stellbrink, J. Schroder, A. Grawe, G. Vogel, R. Blindt, and et al. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents Am J Cardiol 100 9 2007 1347 1352
36. Y.H. Khang, S.I. Cho, and H.R. Kim Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population Atherosclerosis 213 2 2010 579 585
37. G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, and et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis Hypertension 49 1 2007 40 47
38. J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepistö, M. Laakso, and J. Kuusisto The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns Eur Heart J 28 7 2007 857 864
39. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, J.R. Pio, and et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 10 2004 1245 1250
40. K. Shiwaku, E. Anuurad, B. Enkhmaa, A. Nogi, K. Kitajima, K. Shimono, and et al. Overweight Japanese with body mass indexes of 23.0-24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians Int J Obes Relat Metab Disord 28 1 2004 152 158
41. W.L. Lee, A.M. Cheung, D. Cape, and B. Zinman Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies Diabetes Care 23 7 2000 962 968
42. S.J. Nicholls, E.M. Tuzcu, S. Kalidindi, K. Wolski, K.W. Moon, I. Sipahi, and et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials J Am Coll Cardiol 52 4 2008 255 262
43. C.S. Kim, J.S. Choi, E.H. Bae, S.K. Ma, Y.K. Ahn, M.H. Jeong, and et al. Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction Metabolism 62 5 2013 669 676
44. V. Regitz-Zagrosek, E. Lehmkuhl, and S. Mahmoodzadeh Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease Gend Med 4 Suppl. B 2007 S162 S177
45. K. Hunt, H. Lewars, C. Emslie, and G.D. Batty Decreased risk of death from coronary heart disease amongst men with higher 'femininity' scores: a general population cohort study Int J Epidemiol 36 3 2007 612 620
46. J.-P. Després, A. Golay, and L. Sjöström Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia N Engl J Med 353 20 2005 2121 2134